Skip to main content
. 2019 Jan 30;14(1):e0210965. doi: 10.1371/journal.pone.0210965

Fig 2. Study schedule for CT-BI Vacc-4x 2007/1 and CT-BI Vacc-4x 2012/1 clinical studies.

Fig 2

Thick arrows indicate Vacc-4x immunizations. Analyses carried out during the 2012/1 clinical study are shown. Scr.: Screening; ELISPOT: Enzyme-linked Immunosorbent Assay; T-cell prolif.: T-cell proliferation; pvDNA: proviral DNA; DTH: Delayed type hypersensitivity; CD4 and CD8 T-cell counts; VL: viral load.